50% DEXTROSE

50% Dextrose Solution is a potent intravenous glucose preparation used in emergency and critical care settings. Manufactured by Dana Pharmaceuticals Limited in Nigeria, this solution delivers a rapid and concentrated dose of glucose for the management of acute hypoglycemia and other conditions requiring immediate correction of low blood sugar.

Product Overview

Product Name: 50% Dextrose (100 mL) Solution for Infusion

Active Ingredient: Glucose (as Dextrose Monohydrate BP)

Concentration: 50% w/v

Dosage Form: Solution for infusion

Route of Administration: Intravenous (IV)

Pack Size: 100 mL (in clear, colourless glass infusion bottle)

ATC Code: B05BB02

Product Category: Drugs

Marketing Category: Prescription-only Medicine (POM)

Product Description: Solution for Infusion

Regulatory and Manufacturing Information

Applicant Name: Dana Pharmaceuticals Limited

NRN: 04-0859

Status: Active

Approval Date: August 26, 2021

Manufacturer: Dana Pharmaceuticals Limited

Country of Manufacture: Nigeria

Composition

Each 100 mL of solution contains:

Dextrose Monohydrate BP: 50 g (w/v)

Water for Injection: Quantity sufficient to 100 mL

Clinical Uses

50% Dextrose Solution is primarily indicated for:

Emergency Correction of Severe Hypoglycemia: Rapidly raises blood glucose levels in cases of insulin overdose, diabetic coma, or other acute hypoglycemic episodes.

Parenteral Nutrition Support: Used in specific clinical scenarios requiring concentrated glucose supplementation.

Adjunct in Hyperkalemia Management: Used together with insulin in the treatment of hyperkalemia to promote cellular uptake of potassium.

Product Description

This solution is presented in a clear, colourless glass infusion bottle, ensuring product stability and sterility. The high concentration of glucose allows for rapid and effective correction of severe hypoglycemic states with a relatively small infusion volume.